DanielWHauptMD

PubMed

• 139 citations
  Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents.
  Dan W. Haupt, Lisa C. Rosenblatt, M.B.A. Edward Kim, M.B.A. Ross A. Baker, Richard Whitehead, John W. Newcomer> ;The American Journal of Psychiatry. 2009 Mar 1
• 4 citations
  Recognizing and responding to atypical antipsychotic side effects.
  Jeanne M. Jackson-Siegal, Lon S. Schneider, Andrius Baskys, Dan W. Haupt> ;Journal of the American Medical Directors Association. 2004 Jul 1
• Use of adenosine to identify patients at risk for recurrence of accessory pathway conduction after initially successful radiofrequency catheter ablation.
  Walker KW, Silka MJ, Haupt D, Kron J, McAnulty JH, Halperin BD> ;Pacing Clin Electrophysiol. 1995-03-01
• Hyperglycemia and antipsychotic medications.
  Haupt, D. W., Newcomer, J. W.> ;J Clin Psychiatry. 2001
• Risperidone-associated diabetic ketoacidosis.
  Haupt, D. W., Newcomer, J. W.> ;Psychosomatics. 2001 May 01
• Early changes in defibrillation threshold following implantation of a nonthoracotomy system in dogs.
  Halperin, B. D., Haupt, D. W., Lemmer, J. H., Holcomb, S. R., Oliver, R. P., Silka, M. J.> ;Pacing Clin Electrophysiol. 1994 Nov
• Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
  Casey, D. E., Haupt, D. W., Newcomer, J. W., Henderson, D. C., Sernyak, M. J., Davidson, M., Lindenmayer, J. P., Manoukian, S. V., Banerji, M. A., Lebovitz, H. E., Hen...> ;J Clin Psychiatry. 2004
• Abnormalities in glucose regulation associated with mental illness and treatment.
  Haupt, D. W., Newcomer, J. W.> ;J Psychosom Res. 2002 Oct
• Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.
  Newcomer, J. W., Haupt, D. W., Fucetola, R., Melson, A. K., Schweiger, J. A., Cooper, B. P., Selke, G.> ;Arch Gen Psychiatry. 2002 Apr
• Impact of medical comorbidity on medication management of schizophrenia.
  Haupt, D. W.> ;CNS Spectr. 2007 Dec
• Metabolic risks and effects of atypical antipsychotic treatment.
  Haupt, D. W., Kane, J. M.> ;J Clin Psychiatry. 2007 Oct
• Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients.
  Haupt, D. W., Fahnestock, P. A., Flavin, K. A., Schweiger, J. A., Stevens, A., Hessler, M. J., Maeda, J., Yingling, M., Newcomer, J. W.> ;Neuropsychopharmacology. 2007 Dec
• Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice.
  Ketter, T. A., Haupt, D. W.> ;Curr Med Res Opin. 2006 Dec
• The metabolic effects of antipsychotic medications.
  Newcomer, J. W., Haupt, D. W.> ;Can J Psychiatry. 2006 Jul
• Differential metabolic effects of antipsychotic treatments.
  Haupt, D. W.> ;Eur Neuropsychopharmacol. 2006 Sep
• Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
  Haupt, D. W., Luber, A., Maeda, J., Melson, A. K., Schweiger, J. A., Newcomer, J. W.> ;Neuropsychopharmacology. 2005 Jan
• Join now to see all